Mutagenetix > Incidental Mutation

Incidental Mutation 'R6365:Ifi44l'

512620

Institutional Source

Beutler Lab

Gene Symbol

Ifi44l

Ensembl Gene

ENSMUSG00000039146

Gene Name

interferon-induced protein 44 like

Synonyms

H-28, NS1178, H28

MMRRC Submission

044515-MU

Accession Numbers

Essential gene?

Probably non essential (E-score: 0.056) question?

Stock #

R6365 (G1)

Quality Score

225.009

Status

Validated

Chromosome

Chromosomal Location

151464374-151468528 bp(-) (GRCm39)

Type of Mutation

missense

DNA Base Change (assembly)

C to T at 151467142 bp (GRCm39)

Zygosity

Heterozygous

Amino Acid Change

Valine to Isoleucine at position 63 (V63I)

Gene Model

predicted gene model for transcript(s):

AlphaFold

no structure available at present

Predicted Effect

unknown
Transcript: ENSMUST00000046739
AA Change: V63I

SMART Domains

Protein: ENSMUSP00000044765
Gene: ENSMUSG00000039146
AA Change: V63I

Domain	Start	End	E-Value	Type
low complexity region	140	154	N/A	INTRINSIC

Meta Mutation Damage Score

0.0869

Coding Region Coverage

1x: 99.9%
3x: 99.6%
10x: 98.0%
20x: 93.8%

Validation Efficiency

98% (57/58)

MGI Phenotype

FUNCTION: This gene encodes a minor histocompatibility antigen that is involved in tissue graft rejection and is polymorphic in different mouse strains. The 5' region of this gene, including the translational start codon and the first 293 amino acids, is absent from the C57BL/6J genome. The encoded antigen is not thought to be expressed in C57BL/6J. [provided by RefSeq, Mar 2013]

Allele List at MGI

Other mutations in this stock

Total: 60 list
Gene	Ref	Var	Chr/Loc	Mutation	Predicted Effect	Zygosity
2900026A02Rik	G	T	5: 113,330,510 (GRCm39)	R1235S	probably benign	Het
Abca9	T	A	11: 110,036,481 (GRCm39)	I543F	possibly damaging	Het
Acot6	A	G	12: 84,156,186 (GRCm39)	E378G	probably benign	Het
Adam30	T	C	3: 98,068,350 (GRCm39)	L61S	probably damaging	Het
Agap3	T	A	5: 24,679,983 (GRCm39)	L227Q	probably benign	Het
Ap5m1	T	C	14: 49,316,285 (GRCm39)	I285T	probably benign	Het
Atp2a2	A	G	5: 122,599,979 (GRCm39)	Y497H	probably benign	Het
Bace1	C	T	9: 45,765,974 (GRCm39)	Q17*	probably null	Het
Calcr	T	C	6: 3,711,455 (GRCm39)	I189V	probably benign	Het
Cd48	A	T	1: 171,509,732 (GRCm39)	Q24L	probably null	Het
Cnga1	T	C	5: 72,762,288 (GRCm39)	I409V	probably benign	Het
Ctsd	G	A	7: 141,939,314 (GRCm39)	T37M	probably benign	Het
Cyp2c29	T	C	19: 39,296,198 (GRCm39)	S171P	probably damaging	Het
Dnaaf11	A	T	15: 66,325,983 (GRCm39)	S197R	probably benign	Het
Dnah8	G	A	17: 30,967,542 (GRCm39)	D2585N	probably benign	Het
Drd2	A	T	9: 49,318,249 (GRCm39)	N397I	probably damaging	Het
Dst	A	G	1: 34,231,008 (GRCm39)	E3045G	probably damaging	Het
Dzip3	T	A	16: 48,751,636 (GRCm39)	R764S	probably damaging	Het
Efcab3	A	G	11: 104,815,412 (GRCm39)	E3247G	unknown	Het
Exosc10	T	C	4: 148,645,562 (GRCm39)	V114A	probably benign	Het
Fam234a	C	A	17: 26,439,429 (GRCm39)	E32*	probably null	Het
Fbxw11	C	A	11: 32,670,623 (GRCm39)	D162E	possibly damaging	Het
Fcho2	A	T	13: 98,926,367 (GRCm39)	M72K	probably benign	Het
Fech	T	C	18: 64,591,251 (GRCm39)	N391S	probably benign	Het
Foxp2	T	C	6: 15,286,684 (GRCm39)	L58P	probably damaging	Het
Gdi2	A	G	13: 3,615,093 (GRCm39)	D430G	possibly damaging	Het
Grm8	C	T	6: 27,363,226 (GRCm39)	C763Y	probably damaging	Het
H2bc6	C	T	13: 23,769,641 (GRCm39)	R100H	probably benign	Het
Hibch	T	A	1: 52,908,096 (GRCm39)		probably null	Het
Igf1r	G	T	7: 67,839,798 (GRCm39)	A702S	probably benign	Het
Kctd13	G	A	7: 126,529,862 (GRCm39)	R101Q	probably damaging	Het
Klhl33	T	C	14: 51,129,294 (GRCm39)	D645G	probably benign	Het
Mylk	A	G	16: 34,680,961 (GRCm39)	T74A	probably benign	Het
Myo1f	A	G	17: 33,805,090 (GRCm39)	S453G	probably benign	Het
Naxe	A	G	3: 87,965,298 (GRCm39)	V105A	probably damaging	Het
Nid2	A	G	14: 19,853,201 (GRCm39)	Y1140C	probably damaging	Het
Nlrp12	T	C	7: 3,288,518 (GRCm39)	T665A	probably benign	Het
Or51l4	T	A	7: 103,404,402 (GRCm39)	H130L	probably benign	Het
Otud7b	T	G	3: 96,062,567 (GRCm39)	I602S	probably benign	Het
Pakap	G	T	4: 57,709,675 (GRCm39)	G207*	probably null	Het
Papolg	T	C	11: 23,832,290 (GRCm39)	D166G	probably damaging	Het
Pbx4	T	G	8: 70,324,857 (GRCm39)		probably null	Het
Pdcd4	T	C	19: 53,910,564 (GRCm39)		probably null	Het
Pde2a	C	T	7: 101,159,570 (GRCm39)	T800I	probably damaging	Het
Polk	A	T	13: 96,620,517 (GRCm39)	V582E	probably damaging	Het
Prss40	A	G	1: 34,591,598 (GRCm39)		probably benign	Het
Robo4	G	T	9: 37,322,008 (GRCm39)	R597L	probably benign	Het
Scg2	T	A	1: 79,413,017 (GRCm39)	I529F	probably benign	Het
Sema7a	T	C	9: 57,862,188 (GRCm39)	F180L	probably benign	Het
Sowahc	T	C	10: 59,059,349 (GRCm39)	L495P	probably damaging	Het
Trf	A	G	9: 103,099,327 (GRCm39)	V324A	possibly damaging	Het
Uox	C	T	3: 146,330,332 (GRCm39)	R163*	probably null	Het
Vip	C	T	10: 5,594,021 (GRCm39)	R125*	probably null	Het
Vmn1r159	T	A	7: 22,542,826 (GRCm39)	T69S	probably damaging	Het
Vmn1r202	A	T	13: 22,686,374 (GRCm39)	F14L	probably benign	Het
Vmn1r53	T	C	6: 90,201,241 (GRCm39)	N28D	probably damaging	Het
Vmn2r58	T	A	7: 41,513,607 (GRCm39)	K345N	probably benign	Het
Zbtb17	G	A	4: 141,190,694 (GRCm39)	G171S	probably benign	Het
Zbtb8os	A	T	4: 129,236,945 (GRCm39)	N120I	possibly damaging	Het
Zfp959	T	A	17: 56,204,785 (GRCm39)	L274H	probably damaging	Het

Other mutations in Ifi44l

Allele	Source	Chr	Coord	Type	Predicted Effect	PPH Score
IGL02085:Ifi44l	APN	3	151,468,477 (GRCm39)	missense	unknown
R0638:Ifi44l	UTSW	3	151,468,396 (GRCm39)	missense	probably benign	0.13
R1729:Ifi44l	UTSW	3	151,468,456 (GRCm39)	missense	unknown
R3087:Ifi44l	UTSW	3	151,468,494 (GRCm39)	missense	unknown
R4229:Ifi44l	UTSW	3	151,468,514 (GRCm39)	nonsense	probably null
R4230:Ifi44l	UTSW	3	151,468,514 (GRCm39)	nonsense	probably null
R4812:Ifi44l	UTSW	3	151,465,336 (GRCm39)	missense	probably benign	0.00
R5547:Ifi44l	UTSW	3	151,467,142 (GRCm39)	missense	unknown
R7065:Ifi44l	UTSW	3	151,465,429 (GRCm39)	missense
R9796:Ifi44l	UTSW	3	151,468,419 (GRCm39)	missense

Predicted Primers

PCR Primer
(F):5'- TGAACCCACCTTGACCTAATTC -3'
(R):5'- TGGTGCAGTAGCCATATTTCTCAC -3'

Sequencing Primer
(F):5'- ACACACACTAAGCTTGAGGAG -3'
(R):5'- ACCAAGTTTTCAGATTTACTGTGAG -3'

Posted On

2018-04-27